ÂÜÀòÂÒÂ×

Fanny Baylot has extensive experience in the pharmaceutical and healthcare sectors, currently serving as Feasibility Manager at Novo Nordisk since February 2015, where responsibilities include evaluating the feasibility of international clinical trials in France. Previously held roles at Novo Nordisk include Chef de projet Santé Obésité and Business Lead Diabete, focusing on project management and strategic transformations. Fanny's earlier experience includes positions as Global Marketing Manager for Diabetes at AstraZeneca, Associate Marketing Director at BMS, and international product management roles at Boehringer Ingelheim and GlaxoSmithKline France, demonstrating a strong background in marketing strategy, business development, and cross-functional collaboration. Educational qualifications include a Master's degree in medical management from ESCP Business School and specialized studies in Biological Healthcare from the University of Bordeaux II.